Compare Wockhardt with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ELDER PHARMA - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT ELDER PHARMA WOCKHARDT/
ELDER PHARMA
 
P/E (TTM) x -13.6 -0.2 - View Chart
P/BV x 1.1 0.1 1,050.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 WOCKHARDT   ELDER PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
ELDER PHARMA
Jun-14
WOCKHARDT/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs1,012380 266.3%   
Low Rs532188 282.7%   
Sales per share (Unadj.) Rs355.9491.2 72.4%  
Earnings per share (Unadj.) Rs-60.3-3.2 1,894.6%  
Cash flow per share (Unadj.) Rs-46.814.4 -324.5%  
Dividends per share (Unadj.) Rs0.010-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs257.8376.5 68.5%  
Shares outstanding (eoy) m110.6320.54 538.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.20.6 375.1%   
Avg P/E ratio x-12.8-89.3 14.3%  
P/CF ratio (eoy) x-16.519.7 -83.7%  
Price / Book Value ratio x3.00.8 396.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m85,3795,833 1,463.6%   
No. of employees `0006.3NA-   
Total wages/salary Rs m9,3712,179 430.0%   
Avg. sales/employee Rs Th6,295.0NM-  
Avg. wages/employee Rs Th1,498.3NM-  
Avg. net profit/employee Rs Th-1,066.3NM-  
INCOME DATA
Net Sales Rs m39,36910,089 390.2%  
Other income Rs m1,202257 468.6%   
Total revenues Rs m40,57110,346 392.2%   
Gross profit Rs m18-792 -2.3%  
Depreciation Rs m1,495361 413.9%   
Interest Rs m2,5552,756 92.7%   
Profit before tax Rs m-2,830-3,653 77.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5823,713 -96.5%   
Tax Rs m257125 205.4%   
Profit after tax Rs m-6,669-65 10,204.3%  
Gross profit margin %0-7.8 -0.6%  
Effective tax rate %-9.1-3.4 265.1%   
Net profit margin %-16.9-0.6 2,615.0%  
BALANCE SHEET DATA
Current assets Rs m33,7969,240 365.8%   
Current liabilities Rs m26,9179,998 269.2%   
Net working cap to sales %17.5-7.5 -232.7%  
Current ratio x1.30.9 135.9%  
Inventory Days Days7946 171.3%  
Debtors Days Days8960 148.9%  
Net fixed assets Rs m39,66410,124 391.8%   
Share capital Rs m553206 268.9%   
"Free" reserves Rs m27,9685,582 501.0%   
Net worth Rs m28,5227,734 368.8%   
Long term debt Rs m21,7314,889 444.5%   
Total assets Rs m81,62022,882 356.7%  
Interest coverage x-0.1-0.3 33.1%   
Debt to equity ratio x0.80.6 120.5%  
Sales to assets ratio x0.50.4 109.4%   
Return on assets %-5.011.8 -42.9%  
Return on equity %-23.4-0.8 2,766.9%  
Return on capital %-7.722.3 -34.4%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m9,807307 3,198.7%   
Fx outflow Rs m1,789125 1,427.5%   
Net fx Rs m8,019181 4,422.8%   
CASH FLOW
From Operations Rs m68411,754 5.8%  
From Investments Rs m6,302-561 -1,124.4%  
From Financial Activity Rs m-7,695-6,762 113.8%  
Net Cashflow Rs m-6644,432 -15.0%  

Share Holding

Indian Promoters % 74.5 39.6 188.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 7.5 30.7%  
FIIs % 7.7 16.8 45.8%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 36.1 42.7%  
Shareholders   67,757 16,479 411.2%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   ALEMBIC PHARMA  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  ASTRAZENECA PHARMA  BIOCON   

Compare WOCKHARDT With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Higher; IT and Banking Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended higher. Benchmark Indices were highly volatile swinging between positive and negative territory.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Nov 14, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS